Skin Cancer (non-melanoma) SACT consent forms – CRUK

We are pleased to inform you that the Skin Cancer (non-melanoma) SACT consent forms have been reviewed and updated. They are now available on the CRUK website at : www.cruk.org/sact_consent.

A couple of new regimens have been added to the list

  1. Cemiplimab
  2. Vismodegib

Please note that the regimens with cutaneous lymphoma indications have not been updated. They will be reviewed and updated alongside the Lymphoma group which is in progress.

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

Any questions, please do let me know.

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Latest News

By BOPA committee on 4th December 2024

Formation of a network for cancer pharmacists/ pharmacy technicians working alone or in small teams

Calling all District General Hospital Oncology/Haematology Pharmacy professionals! BOPA are facilitating the formation of a network for cancer Pharmacists/Pharmacy Technicians dealing with SACT who are working alone/in small teams to…

Read article
By BOPA Committee on 4th December 2024

Early career pharmacy researcher award (OPERA 2025)

My name is Zita Zachariah and I am the Managing Editor of the Royal Pharmaceutical Society research journals. I am reaching out since we felt that the members of the…

Read article
By BOPA committee on 4th December 2024

RPS calls for Government action to tackle medicines shortage

RPS calls for Government action to tackle medicines shortages Joint letter to Secretary of State for Health and Social Care re medicines shortages – 26 Nov 2024 For more info…

Read article
By BOPA Executive Committee on 2nd December 2024

Pharmacists’ Essential Guide to Haematology – March 2025 (UCLH Cancer Academy)

Dear All, After the hugely successful event that took place in September, UCLH Cancer Academy would like to invite you to an educational program designed to help pharmacists’ understanding of…

Read article